Literature DB >> 17503331

Defining the cause of skewed X-chromosome inactivation in X-linked mental retardation by use of a mouse model.

Mary R Muers1, Jacqueline A Sharpe, David Garrick, Jacqueline Sloane-Stanley, Patrick M Nolan, Terry Hacker, William G Wood, Douglas R Higgs, Richard J Gibbons.   

Abstract

Extreme skewing of X-chromosome inactivation (XCI) is rare in the normal female population but is observed frequently in carriers of some X-linked mutations. Recently, it has been shown that various forms of X-linked mental retardation (XLMR) have a strong association with skewed XCI in female carriers, but the mechanisms underlying this skewing are unknown. ATR-X syndrome, caused by mutations in a ubiquitously expressed, chromatin-associated protein, provides a clear example of XLMR in which phenotypically normal female carriers virtually all have highly skewed XCI biased against the X chromosome that harbors the mutant allele. Here, we have used a mouse model to understand the processes causing skewed XCI. In female mice heterozygous for a null Atrx allele, we found that XCI is balanced early in embryogenesis but becomes skewed over the course of development, because of selection favoring cells expressing the wild-type Atrx allele. Unexpectedly, selection does not appear to be the result of general cellular-viability defects in Atrx-deficient cells, since it is restricted to specific stages of development and is not ongoing throughout the life of the animal. Instead, there is evidence that selection results from independent tissue-specific effects. This illustrates an important mechanism by which skewed XCI may occur in carriers of XLMR and provides insight into the normal role of ATRX in regulating cell fate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17503331      PMCID: PMC1867101          DOI: 10.1086/518369

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  44 in total

1.  Circulation is established in a stepwise pattern in the mammalian embryo.

Authors:  Kathleen E McGrath; Anne D Koniski; Jeffrey Malik; James Palis
Journal:  Blood       Date:  2002-10-24       Impact factor: 22.113

2.  The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies.

Authors:  Yutong Xue; Richard Gibbons; Zhijiang Yan; Dafeng Yang; Tarra L McDowell; Salvatore Sechi; Jun Qin; Sharleen Zhou; Doug Higgs; Weidong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-02       Impact factor: 11.205

3.  Genetic and parent-of-origin influences on X chromosome choice in Xce heterozygous mice.

Authors:  Lisa Helbling Chadwick; Huntington F Willard
Journal:  Mamm Genome       Date:  2005-10-20       Impact factor: 2.957

Review 4.  Hematopoiesis in the yolk sac: more than meets the eye.

Authors:  Kathleen E McGrath; James Palis
Journal:  Exp Hematol       Date:  2005-09       Impact factor: 3.084

5.  X chromosome-inactivation patterns of 1,005 phenotypically unaffected females.

Authors:  James M Amos-Landgraf; Amy Cottle; Robert M Plenge; Mike Friez; Charles E Schwartz; John Longshore; Huntington F Willard
Journal:  Am J Hum Genet       Date:  2006-07-27       Impact factor: 11.025

Review 6.  Yolk-sac hematopoiesis: the first blood cells of mouse and man.

Authors:  J Palis; M C Yoder
Journal:  Exp Hematol       Date:  2001-08       Impact factor: 3.084

Review 7.  Monogenic causes of X-linked mental retardation.

Authors:  J Chelly; J L Mandel
Journal:  Nat Rev Genet       Date:  2001-09       Impact factor: 53.242

8.  Genetic control of X chromosome inactivation in mice: definition of the Xce candidate interval.

Authors:  Lisa Helbling Chadwick; Lisa M Pertz; Karl W Broman; Marisa S Bartolomei; Huntington F Willard
Journal:  Genetics       Date:  2006-04-02       Impact factor: 4.562

9.  Skewed X-chromosome inactivation is a common feature of X-linked mental retardation disorders.

Authors:  Robert M Plenge; Roger A Stevenson; Herbert A Lubs; Charles E Schwartz; Huntington F Willard
Journal:  Am J Hum Genet       Date:  2002-05-30       Impact factor: 11.025

10.  Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues.

Authors:  David Garrick; Jackie A Sharpe; Ruth Arkell; Lorraine Dobbie; Andrew J H Smith; William G Wood; Douglas R Higgs; Richard J Gibbons
Journal:  PLoS Genet       Date:  2006-04-21       Impact factor: 5.917

View more
  12 in total

Review 1.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

2.  α-Thalassemia, mental retardation, and myelodysplastic syndrome.

Authors:  Richard J Gibbons
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

3.  Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier.

Authors:  Christian P Bradley; Cai Chen; Karolyn A Oetjen; Cheng Yan; Reema Panjwani; Sara Hauffe; Katherine R Calvo; Constance Yuan; Prapti Arvind Patel; Nathan D Montgomery; Matthew C Foster; Minoo Battiwalla; A John Barrett; Richard J Gibbons; Sawa Ito
Journal:  Blood Adv       Date:  2019-09-10

Review 4.  Role of ATRX in chromatin structure and function: implications for chromosome instability and human disease.

Authors:  Rabindranath De La Fuente; Claudia Baumann; Maria M Viveiros
Journal:  Reproduction       Date:  2011-06-08       Impact factor: 3.906

Review 5.  The role of genetics in the establishment and maintenance of the epigenome.

Authors:  Covadonga Huidobro; Agustin F Fernandez; Mario F Fraga
Journal:  Cell Mol Life Sci       Date:  2013-03-10       Impact factor: 9.261

6.  The first case of X-linked Alpha-thalassemia/mental retardation (ATR-X) syndrome in Korea.

Authors:  Ki Wook Yun; Soo Ahn Chae; Jung Ju Lee; Sin Weon Yun; Byoung Hoon Yoo; In Seok Lim; Eung Sang Choi; Mi-Kyung Lee
Journal:  J Korean Med Sci       Date:  2010-12-22       Impact factor: 2.153

7.  Lack of Cul4b, an E3 ubiquitin ligase component, leads to embryonic lethality and abnormal placental development.

Authors:  Baichun Jiang; Wei Zhao; Jupeng Yuan; Yanyan Qian; Wenjie Sun; Yongxin Zou; Chenhong Guo; Bingxi Chen; Changshun Shao; Yaoqin Gong
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

8.  ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene Signatures.

Authors:  Zulekha A Qadeer; David Valle-Garcia; Dan Hasson; Zhen Sun; April Cook; Christie Nguyen; Aroa Soriano; Anqi Ma; Lyra M Griffiths; Maged Zeineldin; Dan Filipescu; Luz Jubierre; Asif Chowdhury; Orla Deevy; Xiang Chen; David B Finkelstein; Armita Bahrami; Elizabeth Stewart; Sara Federico; Soledad Gallego; Fumiko Dekio; Mary Fowkes; David Meni; John M Maris; William A Weiss; Stephen S Roberts; Nai-Kong V Cheung; Jian Jin; Miguel F Segura; Michael A Dyer; Emily Bernstein
Journal:  Cancer Cell       Date:  2019-10-17       Impact factor: 38.585

9.  Analysis of X chromosome inactivation in autism spectrum disorders.

Authors:  Xiaohong Gong; Elena Bacchelli; Francesca Blasi; Claudio Toma; Catalina Betancur; Pauline Chaste; Richard Delorme; Christelle M Durand; Fabien Fauchereau; Hany Goubran Botros; Marion Leboyer; Marie-Christine Mouren-Simeoni; Gudrun Nygren; Henrik Anckarsäter; Maria Rastam; I Carina Gillberg; Christopher Gillberg; Daniel Moreno-De-Luca; Simona Carone; Ilona Nummela; Mari Rossi; Agatino Battaglia; Irma Jarvela; Elena Maestrini; Thomas Bourgeron
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-09-05       Impact factor: 3.568

10.  Skewed X inactivation is associated with phenotype in a female with adrenal hypoplasia congenita.

Authors:  M G Shaikh; L Boyes; H Kingston; R Collins; G T N Besley; B Padmakumar; O Ismayl; I Hughes; C M Hall; C Hellerud; J C Achermann; P E Clayton
Journal:  J Med Genet       Date:  2008-09       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.